Navigation Links
CMC Biologics Expands Its Production Facility and Rebrands Its Corporate Identity
Date:6/22/2011

COPENHAGEN, Denmark and SEATTLE, Wash., June 22, 2011 /PRNewswire/ -- CMC Biologics today announced that it is in the final stages of expanding its stainless steel biopharmaceutical production facility at its Bothell campus and it has rebranded its corporate identity with an exciting new logo and a compelling tagline. These recent changes are part of the continued growth of the Company.

(Logo:  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO)

The Company is completing the expansion of its state-of-the-art stainless steel biopharmaceutical manufacturing facility, known as PF2, to increase capacity and support commercial manufacturing with the addition of a 3,000 liter bioreactor train. The modification of PF2 is part of a staged major expansion plan that started with the construction of a multipurpose single-use facility (PF1), completed in 2010, and is expected to include the build-out of a facility to house two 5,000 liter commercial-ready manufacturing lines.

"We measure our success by the results we deliver to our customers," said Gustavo F. Mahler, Ph.D., Global Chief Operations Officer of CMC Biologics. "The expansion of PF2 will add significant production capacity to CMC Biologics' existing facilities to accommodate growing demand for cGMP manufacture of biopharmaceuticals."

"The rebranding, which coincides with the Company's tenth anniversary, isn't just about a new logo. It's about our reputation and image in the market," noted Claes Glassell, CEO of CMC Biologics. "The new tagline 'Right. On Time.' conveys our commitment to our customers."

About CMC Biologics

CMC Biologics (www.cmcbio.com) is a dedicated contract biopharmaceutical manufacturing and development organization with facilities in Copenhagen, Denmark and Seattle, Washington, USA. CMC Biologics specializes in custom services for scale up
'/>"/>

SOURCE CMC Biologics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
2. Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
3. Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc.
4. Savient Submits Biologics License Application (BLA) for pegloticase
5. DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter
6. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
7. Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
8. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
9. Bone Biologics Announces UCB-1 (NELL-1) Bone Growth Protein Production Process With Aragen Biosciences
10. Frost & Sullivan Recognizes ApaTechs Leadership in Orthopedic Biologics
11. LaVoie Group Adds Bio-Surgery Company, Pegasus Biologics, to Its Life Sciences Agency Roster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014 A long-term retrospective study of ... (APBI) via interstitial brachytherapy suggests that women younger ... could be suitable to receive the treatment. Current ... these patients in the "unsuitable" category for APBI. ... meeting, Beaumont Health System,s Peter Y. Chen ...
(Date:9/17/2014)... September 17, 2014 Shimadzu ... Liquid Chromatograph (2D-LC), which offers a powerful ... matrices. The system provides a new level ... which is beneficial to scientists analyzing pharmaceutical ... natural products. , Comprehensive 2D-LC combines two ...
(Date:9/17/2014)... Hershey, PA & Rockville, MD (PRWEB) September 17, 2014 ... it won a Small Business Innovation Research (SBIR) grant ... allergy immunotherapy. The award will provide ITI with approximately ... , Tree nuts, a leading cause of food allergy, ... leading cause of anaphylaxis behind peanut allergy. Tree nut ...
(Date:9/17/2014)... SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), a life ... products for advanced microarray diagnostics, today announced that its ... the United States on the OTCQX ... 17, 2014 on the OTCQX under the symbol SQIDF.  ... Venture Exchange under its existing symbol SQD. ...
Breaking Biology Technology:Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 2Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 3Partial Breast Irradiation With Interstitial Brachytherapy Appears Appropriate For Women Previously Considered Unsuitable 4Shimadzu’s New Nexera-e Two Dimensional Comprehensive Liquid Chromatograph Empowers Laboratories to Separate Even the Most Complex Mixtures 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 2SQI Diagnostics to begin Trading on the OTCQX Marketplace in the United States 3
... Gen-Probe Incorporated (NASDAQ: GPRO ) announced today ... results on Thursday, April 28, 2011 at approximately 4:00 pm ... conference call with management at 4:30 pm ET.   ... be accessed on the investors section of the Company,s web ...
... 14, 2011 /PRNewswire-Asia/ -- Global Pharm Holdings Group, Inc. ... or the "Company"), a Shenzhen-based, leading vertically integrated pharmaceutical ... its subsidiaries in Anhui, Jilin, and Shandong provinces, today ... 31, 2010. Fiscal Year 2010 Highlights ...
... TRIANGLE PARK, N.C., April 14, 2011 Talecris Biotherapeutics Holdings ... quarter earnings release after the market closes on April 27, ... will not be hosting a conference call to discuss its ... Inspiration. Dedication. Innovation. Talecris ...
Cached Biology Technology:Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call 2Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 2Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 3Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 4Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 5Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 6Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 7Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 8Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results 9
(Date:9/16/2014)... Researchers at the Columbia Center for Children,s Environmental Health ... first to demonstrate an association between childhood asthma and ... array of household products. Results appear online in the ... born to mothers exposed during pregnancy to higher levels ... (DnBP) had a 72 percent and 78 percent increase ...
(Date:9/16/2014)... neuroscientists have discovered the "molecular brakes" that time the ... of mice. These "hair cells" translate sound waves into ... are interpreted as sounds. If the arrangement of the ... summary of the research will be published in ... "The proteins Hey1 and Hey2 act as brakes to ...
(Date:9/16/2014)... EUGENE, Ore. -- Each tree species has its own ... researchers and colleagues from other institutions who studied the ... growing on a Panamanian island. , "This study demonstrates ... plant families and with different ecological strategies possess very ... Steven W. Kembel, a former postdoctoral researcher in the ...
Breaking Biology News(10 mins):Phthalates heighten risk for childhood asthma 2Phthalates heighten risk for childhood asthma 3Hey1 and Hey2 ensure inner ear 'hair cells' are made at the right time, in the right place 2Microbiome research shows each tree species has a unique bacterial identity 2
... WEST LAFAYETTE, Ind. - Researchers at Purdue University have ... in spinal cord injuries using nano-spheres that could be ... The synthetic "copolymer micelles" are drug-delivery spheres about 60 ... the diameter of a red blood cell. Researchers ...
... To celebrate the 150th anniversary this month of ... American Institute of Biological Sciences (AIBS) is publishing open ... historic insights into evolution. , The two articles are ... and James T. Costa of Western Carolina University. Padian,s ...
... The National Association of Biology Teachers (NABT) will ... at Naugatuck Valley Community College (NVCC) in Waterbury, ... the NABT annual professional development conference to be ... The Evolution Education Award is cosponsored by the ...
Cached Biology News:Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2
... The TargeTron(TM) Gene Knockout System provides optimized ... specific disruption of bacterial genes by insertion ... the retrohoming ability of group II introns ... re-target the TargeTron group II intron for ...
... a partial recombinant MAK. Immunogen: ... partial recombinant protein with GST tag. ... Accession: BC039825 Protein Accession ... 154235, GeneID: 4117 ...
...
Mouse polyclonal antibody raised against a partial recombinant DDEF2. NCBI Entrez Gene ID = 8853...
Biology Products: